JOSHUA ROSENBERG, MD
Hematology & Oncology Physician · VENTURA, CA
Individual Active NPI 1124280896
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 509 | 145,178 | $20,276,450 | $3,794,141 | $3,015,660 |
| 2023 | 443 | 139,990 | $17,177,072 | $3,244,412 | $2,576,526 |
| 2022 | 397 | 96,093 | $11,784,702 | $2,469,830 | $1,963,072 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 11,730 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,350 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 8,800 | $56 | $45 |
| J0897 | Injection, denosumab, 1 mg | 3,720 | $26 | $21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,374 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,370 | $1 | $1 |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 939 | $8 | $8 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 732 | $17 | $13 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 704 | $0 | $0 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 605 | $192 | $146 |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 600 | $139 | $110 |
| 96375 | Injection of additional new drug or substance into vein | 506 | $17 | $14 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | A107148 | CA |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in California
- NPI 1053350231
- NPI 1376787416
- NPI 1689735227
- NPI 1053621730
- NPI 1952356933
- NPI 1891322459
- NPI 1720200363
- NPI 1801076633
See all Hematology & Oncology Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.